Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 1 |
2019 | 2 |
2020 | 3 |
2021 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Immune Checkpoint Inhibitors: A Promising Choice for Endometrial Cancer Patients?
J Clin Med. 2020 Jun 3;9(6):1721. doi: 10.3390/jcm9061721.
J Clin Med. 2020.
PMID: 32503218
Free PMC article.
Review.
Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer.
Sassu CM, Palaia I, Boccia SM, Caruso G, Perniola G, Tomao F, Di Donato V, Musella A, Muzii L.
Sassu CM, et al. Among authors: boccia sm.
Int J Mol Sci. 2021 Dec 20;22(24):13650. doi: 10.3390/ijms222413650.
Int J Mol Sci. 2021.
PMID: 34948446
Free PMC article.
Review.
Item in Clipboard
Cervical cancer: are there potential new targets? An update on preclinical and clinical results.
Tomao F, Di Tucci C, Imperiale L, Boccia SM, Marchetti C, Palaia I, Muzii L, Panici PB.
Tomao F, et al. Among authors: boccia sm.
Curr Drug Targets. 2014;15(12):1107-20. doi: 10.2174/1389450115666141010145547.
Curr Drug Targets. 2014.
PMID: 25300780
Review.
Item in Clipboard
First-Line Treatment with Olaparib for Early Stage BRCA-Positive Ovarian Cancer: May It Be Possible? Hypothesis Potentially Generating a Line of Research.
Tomao F, Boccia SM, Sassu CM, Chirra M, Palaia I, Petrella MC, Di Donato V, Colombo N, Benedetti Panici P.
Tomao F, et al. Among authors: boccia sm.
Cancer Manag Res. 2020 Jul 7;12:5479-5489. doi: 10.2147/CMAR.S194874. eCollection 2020.
Cancer Manag Res. 2020.
PMID: 32765062
Free PMC article.
Review.
Item in Clipboard
Trabectedin plus pegylated liposomal doxorubicin in patients with disease progression after PARP inhibitor maintenance: a real-life case-control study.
Vertechy L, Boccia SM, Tiberi G, Avesani G, Corrado G, Fagotti A, Scambia G, Marchetti C.
Vertechy L, et al. Among authors: boccia sm.
Int J Gynecol Cancer. 2023 Feb 6;33(2):243-249. doi: 10.1136/ijgc-2022-003764.
Int J Gynecol Cancer. 2023.
PMID: 36564097
Item in Clipboard
Severe hemoperitoneum due to endometriosis in a non-pregnant woman under dienogest therapy: a case report.
Palaia I, Bardhi E, Boccia SM, Pecorini F, Musella A, Panici PB.
Palaia I, et al. Among authors: boccia sm.
Gynecol Endocrinol. 2020 Mar;36(3):211-212. doi: 10.1080/09513590.2019.1653843. Epub 2019 Aug 13.
Gynecol Endocrinol. 2020.
PMID: 31407617
Item in Clipboard
Is BRCA mutational status a predictor of platinum-based chemotherapy related hematologic toxicity in high-grade serous ovarian cancer patients?
Tomao F, Musacchio L, Di Mauro F, Boccia SM, Di Donato V, Giancotti A, Perniola G, Palaia I, Muzii L, Benedetti Panici P.
Tomao F, et al. Among authors: boccia sm.
Gynecol Oncol. 2019 Jul;154(1):138-143. doi: 10.1016/j.ygyno.2019.04.009. Epub 2019 May 9.
Gynecol Oncol. 2019.
PMID: 31079832
Item in Clipboard
Cite
Cite